Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392,193,323
-
Total 13F shares
-
376,420,513
-
Share change
-
+8,411,503
-
Total reported value
-
$46,714,761,535
-
Put/Call ratio
-
142%
-
Price per share
-
$124.09
-
Number of holders
-
963
-
Value change
-
+$1,256,458,516
-
Number of buys
-
458
-
Number of sells
-
468
Institutional Holders of DEXCOM INC - Common Stock (DXCM) as of Q4 2023
As of 31 Dec 2023,
DEXCOM INC - Common Stock (DXCM) was held by
963 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
376,420,513 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, Capital Research Global Investors, SANDS CAPITAL MANAGEMENT, LLC, Capital World Investors, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, and Nuveen Asset Management, LLC.
This page lists
963
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.